These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 35571034)

  • 61. A Signature of Nine lncRNA Methylated Genes Predicts Survival in Patients With Glioma.
    Cheng M; Sun L; Huang K; Yue X; Chen J; Zhang Z; Zhao B; Bian E
    Front Oncol; 2021; 11():646409. PubMed ID: 33828990
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Computational detection of a genome instability-derived lncRNA signature for predicting the clinical outcome of lung adenocarcinoma.
    Guo CR; Mao Y; Jiang F; Juan CX; Zhou GP; Li N
    Cancer Med; 2022 Feb; 11(3):864-879. PubMed ID: 34866362
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Using Immune-Related lncRNA Signature for Prognosis and Response to Immunotherapy in Cutaneous Melanoma.
    Xue L; Wu P; Zhao X; Jin X; Wang J; Shi Y; Yang X; She Y; Li Y; Li C
    Int J Gen Med; 2021; 14():6463-6475. PubMed ID: 34675614
    [TBL] [Abstract][Full Text] [Related]  

  • 64. High expression of stromal signatures correlated with macrophage infiltration, angiogenesis and poor prognosis in glioma microenvironment.
    Tian Y; Ke Y; Ma Y
    PeerJ; 2020; 8():e9038. PubMed ID: 32509446
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Long non-coding RNAs correlate with genomic stability in prostate cancer: A clinical outcome and survival analysis.
    Jianfeng W; Yutao W; Jianbin B
    Genomics; 2021 Sep; 113(5):3141-3151. PubMed ID: 34174340
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Identification of a novel immune-related lncRNA signature to predict prognostic outcome and therapeutic efficacy of LGG.
    Wu D; Wang X; Xue Y; Sun C; Zhang M
    J Integr Neurosci; 2022 Mar; 21(2):55. PubMed ID: 35364643
    [TBL] [Abstract][Full Text] [Related]  

  • 67. A novel immune-related ceRNA network that predicts prognosis and immunotherapy response in lung adenocarcinoma.
    Gong WJ; Zhou T; Wu SL; Huang YF; Xiang LP; Xu JQ; Han Y; Lv YN; Zeng F; Zhang Y
    Ann Transl Med; 2021 Sep; 9(18):1484. PubMed ID: 34734036
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Identification of Mutator-Derived lncRNA Signatures of Genomic Instability for Promoting the Clinical Outcome in Hepatocellular Carcinoma.
    Tang X; Miao Y; Wang J; Cai T; Yang L; Mi D
    Comput Math Methods Med; 2021; 2021():1205029. PubMed ID: 34840594
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Comprehensive Analysis of N6-Methyladenosine-Related IncRNAs Prognostic Signature and the Associated Immune Infiltrates in Kidney Renal Clear Cell Carcinoma.
    Chen X; Wang L; Tu J; Pan X; Li Y; Yin H; Wang M; Yuan X
    Crit Rev Eukaryot Gene Expr; 2022; 32(1):79-98. PubMed ID: 35377983
    [TBL] [Abstract][Full Text] [Related]  

  • 70. A Prognostic Signature for Lower Grade Gliomas Based on Expression of Long Non-Coding RNAs.
    Kiran M; Chatrath A; Tang X; Keenan DM; Dutta A
    Mol Neurobiol; 2019 Jul; 56(7):4786-4798. PubMed ID: 30392137
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Construction and validation of immune-related LncRNAs classifier to predict prognosis and immunotherapy response in laryngeal squamous cell carcinoma.
    Wang X; Pan Y; Ou Y; Duan T; Zou Y; Zhou X
    World J Surg Oncol; 2022 May; 20(1):164. PubMed ID: 35606755
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Long Non-Coding RNAs in Gliomas: From Molecular Pathology to Diagnostic Biomarkers and Therapeutic Targets.
    Vecera M; Sana J; Lipina R; Smrcka M; Slaby O
    Int J Mol Sci; 2018 Sep; 19(9):. PubMed ID: 30217088
    [TBL] [Abstract][Full Text] [Related]  

  • 73. A Novel Pyroptosis-Associated Long Non-coding RNA Signature Predicts Prognosis and Tumor Immune Microenvironment of Patients With Breast Cancer.
    Ping L; Zhang K; Ou X; Qiu X; Xiao X
    Front Cell Dev Biol; 2021; 9():727183. PubMed ID: 34616734
    [No Abstract]   [Full Text] [Related]  

  • 74. An Immune-Related lncRNA Signature to Predict Survival In Glioma Patients.
    Xia P; Li Q; Wu G; Huang Y
    Cell Mol Neurobiol; 2021 Mar; 41(2):365-375. PubMed ID: 32410107
    [TBL] [Abstract][Full Text] [Related]  

  • 75. An m6A/m5C/m1A/m7G-Related Long Non-coding RNA Signature to Predict Prognosis and Immune Features of Glioma.
    Shao D; Li Y; Wu J; Zhang B; Xie S; Zheng X; Jiang Z
    Front Genet; 2022; 13():903117. PubMed ID: 35692827
    [No Abstract]   [Full Text] [Related]  

  • 76. Analysis of the prognostic significance and potential mechanisms of lncRNAs associated with m6A methylation in papillary thyroid carcinoma.
    Huang Y; Li X; Chen W; He Y; Wu S; Li X; Hou B; Wang S; He Y; Jiang H; Lun Y; Zhang J
    Int Immunopharmacol; 2021 Dec; 101(Pt B):108286. PubMed ID: 34735975
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Genome instability-related long non-coding RNA in clear renal cell carcinoma determined using computational biology.
    Wang Y; Yan K; Wang L; Bi J
    BMC Cancer; 2021 Jun; 21(1):727. PubMed ID: 34167490
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Up-regulation of the long non-coding RNA RMRP contributes to glioma progression and promotes glioma cell proliferation and invasion.
    Feng W; Li L; Xu X; Jiao Y; Du W
    Arch Med Sci; 2017 Oct; 13(6):1315-1321. PubMed ID: 29181061
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Identification of m6A methyltransferase-related lncRNA signature for predicting immunotherapy and prognosis in patients with hepatocellular carcinoma.
    Li L; Xie R; Lu G
    Biosci Rep; 2021 Jun; 41(6):. PubMed ID: 34027555
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Long non-coding RNA profile study identifies an immune-related lncRNA prognostic signature for prostate adenocarcinoma.
    Liang L; Xia W; Yao L; Wu Q; Hua L; Cheng G; Wang Z; Zhao R
    Int Immunopharmacol; 2021 Dec; 101(Pt A):108267. PubMed ID: 34740081
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.